Apple (AAPL) says it will disable a blood-oxygen monitoring feature on its Apple Watch Series 9 or Ultra 2 watches in the U.S. beginning Thursday to comply with a court-ordered revival of a sales ban stemming from a patent dispute, according to AP and other media outlets. The U.S. International Trade Commission in late October ruled a blood-oxygen sensor in the Apple Watch models infringed on patents held by medical technology company Masimo (MASI).
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AAPL: